SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications

Vitamin D analogues with reduced hypercalcemic activity are under clinical investigation for use against colon cancer and other neoplasias. However, only a subset of patients responds to this therapy, most probably due to loss of vitamin D receptor (VDR) expression during tumour progression. Recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Larriba, M J, Muñoz, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361934/
https://www.ncbi.nlm.nih.gov/pubmed/15770204
http://dx.doi.org/10.1038/sj.bjc.6602484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361934/
https://www.ncbi.nlm.nih.gov/pubmed/15770204
http://dx.doi.org/10.1038/sj.bjc.6602484

Ejemplares similares